Patents by Inventor Christine M. Steinhart

Christine M. Steinhart has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9993580
    Abstract: Osteogenic compositions include a decellularized extracellular matrix tissue and bone morphogenic protein, preferably BMP-2. The compositions make beneficial use of the BMP, which can be used at relatively low doses and can bind to native components (e.g., native sulfated glycosaminoglycans such as heparin and/or heparan sulfate) remaining in the decellularized extracellular matrix tissue. Methods for preparation and use of such compositions are also described. The compositions and related methods can be used in the treatment of diseased or damaged bone tissue.
    Type: Grant
    Filed: March 2, 2016
    Date of Patent: June 12, 2018
    Assignee: Muffin Incorporated
    Inventors: Shelley Lynn Scoville, Amanda F. Taylor, Steven Charlebois, Christine M. Steinhart, Neal E. Fearnot
  • Publication number: 20160263282
    Abstract: Osteogenic compositions include a decellularized extracellular matrix tissue and bone morphogenic protein, preferably BMP-2. The compositions make beneficial use of the BMP, which can be used at relatively low doses and can bind to native components (e.g., native sulfated glycosaminoglycans such as heparin and/or heparan sulfate) remaining in the decellularized extracellular matrix tissue. Methods for preparation and use of such compositions are also described. The compositions and related methods can be used in the treatment of diseased or damaged bone tissue.
    Type: Application
    Filed: March 2, 2016
    Publication date: September 15, 2016
    Inventors: Shelly L. Wallace, Amanda F. Taylor, Steven Charlebois, Christine M. Steinhart, Neal E. Fearnot
  • Publication number: 20150065425
    Abstract: Osteogenic compositions include a decellularized extracellular matrix tissue and bone morphogenic protein, preferably BMP-2. The compositions make beneficial use of the BMP, which can be used at relatively low doses and can bind to native components (e.g., native sulfated glycosaminoglycans such as heparin and/or heparan sulfate) remaining in the decellularized extracellular matrix tissue. Methods for preparation and use of such compositions are also described. The compositions and related methods can be used in the treatment of diseased or damaged bone tissue.
    Type: Application
    Filed: September 2, 2014
    Publication date: March 5, 2015
    Inventors: Shelley L. Wallace, Amanda F. Taylor, Steven Charlebois, Christine M. Steinhart, Neal E. Fearnot
  • Publication number: 20150065947
    Abstract: Compositions and methods for treating diseased or damaged bone, preferably ischemic and/or necrotic bone, include the use of a combination of endothelial progenitor cells and mesenchymal stem cells, desirably also in conjunction with a collagenous extracellular matrix tissue. Methods for preparation of such compositions are also described.
    Type: Application
    Filed: August 29, 2014
    Publication date: March 5, 2015
    Inventors: Shelley L. Wallace, Amanda F. Taylor, Steven Charlebois, Christine M. Steinhart, Neal E. Fearnot